Capital Performance Advisors »

Soleno Therapeutics shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $858 17 50.47

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Specialized Funds Div App Etf (VIG)
NVIDIA Corporation (NVDA)

View all positions for Capital Performance Advisors

Top funds holding Soleno Therapeutics

Vivo Capital
Henderson Group
Nantahala Capital Management
Adage Capital Partners GP
Susquehanna International
venBio Select Advisor
BlackRock
Vanguard Group
T. Rowe Price Associates
Perceptive Advisors
Carlyle
State Street Corporation
Citadel Advisors
Commodore Capital
Caption Management

View all funds holding Soleno Therapeutics